MedTrace Logo

The Effects on Growth and Tolerance of an Infant Formula Fed to Term Infants

NCT01897922 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 348

Last updated 2015-09-25

No results posted yet for this study

Summary

This clinical trial will evaluate an investigational infant formula with a probiotic to determine if it provides normal growth and if it is well tolerated by term infants compared to a marketed routine infant formula.

Conditions

  • Growth of Term Infants

Interventions

OTHER

An investigational infant formula containing a probiotic source

OTHER

Control: Marketed routine infant formula

Sponsors & Collaborators

  • Mead Johnson Nutrition

    lead INDUSTRY

Principal Investigators

  • Carol Lynn Berseth, M.D. · Mead Johnson Nutrition

Study Design

Allocation
RANDOMIZED
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
12 Days
Max Age
16 Days
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-07-31
Primary Completion
2014-03-31
Completion
2014-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01897922 on ClinicalTrials.gov